Login
Home
Charts
Search
Watchlist
Products

Rossari Biotech Ltd

ROSSARI·NSE
₹442.25+0.28%Tue, 22 Sept '26 15:54
Industry:Seeds/Tissue Culture/Bio Technology
Indices:

Rossari Biotech Ltd

ROSSARI
NSE
₹442.25
+0.28%
|Tue, 22 Sept '26 15:54
SOICxStockScans Reports
Industry
Seeds/Tissue Culture/Bio Technology
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,421Cr
Close
Close Price
₹437.05
Industry
Industry
Seeds/Tissue Culture/Bio Technology
PE
Price To Earnings
16.06
PS
Price To Sales
0.95
Revenue
Revenue
₹2,550Cr
Rev Gr TTM
Revenue Growth TTM
19.47%
PAT Gr TTM
PAT Growth TTM
11.59%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
483464473490498513580544586582685697
Growth YoY
Revenue Growth YoY%
13.619.116.319.33.110.622.611.017.613.418.228.2
Expenses
ExpensesCr
420400409425432448510476514513608617
Operating Profit
Operating ProfitCr
646464656665696872697781
OPM
OPM%
13.213.713.413.313.212.612.012.512.311.811.311.6
Other Income
Other IncomeCr
1411112221204
Interest Expense
Interest ExpenseCr
5434456668911
Depreciation
DepreciationCr
151516151518181818202426
PBT
PBTCr
454846474842484650436448
Tax
TaxCr
121311121311131313101813
PAT
PATCr
333434353532343437334635
Growth YoY
PAT Growth YoY%
37.833.917.819.47.2-7.80.9-3.74.43.433.54.5
NPM
NPM%
6.87.47.27.17.16.25.96.26.35.66.75.0
EPS
EPS₹
6.06.26.26.36.45.76.26.16.75.98.36.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
483464473490498513580544586582685697
Growth YoY
Revenue Growth YoY%
13.619.116.319.33.110.622.611.017.613.418.228.2
Expenses
ExpensesCr
420400409425432448510476514513608617
Operating Profit
Operating ProfitCr
646464656665696872697781
OPM
OPM%
13.213.713.413.313.212.612.012.512.311.811.311.6
Other Income
Other IncomeCr
1411112221204
Interest Expense
Interest ExpenseCr
5434456668911
Depreciation
DepreciationCr
151516151518181818202426
PBT
PBTCr
454846474842484650436448
Tax
TaxCr
121311121311131313101813
PAT
PATCr
333434353532343437334635
Growth YoY
PAT Growth YoY%
37.833.917.819.47.2-7.80.9-3.74.43.433.54.5
NPM
NPM%
6.87.47.27.17.16.25.96.26.35.66.75.0
EPS
EPS₹
6.06.26.26.36.45.76.26.16.75.98.36.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5166007091,4831,6561,8312,0802,3962,550
Growth
Revenue Growth%
16.318.2109.111.710.613.615.219.5
Expenses
ExpensesCr
4394955861,3001,4331,5811,8152,1102,251
Operating Profit
Operating ProfitCr
78105124183223250265286299
OPM
OPM%
15.017.417.412.413.513.612.711.911.7
Other Income
Other IncomeCr
149146852426
Interest Expense
Interest ExpenseCr
343132219182934
Depreciation
DepreciationCr
121723486360677987
PBT
PBTCr
6388107136144178185203204
Tax
TaxCr
182327393747495353
PAT
PATCr
46658098107131136149151
Growth
PAT Growth%
42.822.722.19.821.94.39.411.6
NPM
NPM%
8.810.911.36.66.57.16.66.25.9
EPS
EPS₹
9.413.415.617.819.523.724.726.927.2
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5166007091,4831,6561,8312,0802,3962,550
Growth
Revenue Growth%
16.318.2109.111.710.613.615.219.5
Expenses
ExpensesCr
4394955861,3001,4331,5811,8152,1102,251
Operating Profit
Operating ProfitCr
78105124183223250265286299
OPM
OPM%
15.017.417.412.413.513.612.711.911.7
Other Income
Other IncomeCr
149146852426
Interest Expense
Interest ExpenseCr
343132219182934
Depreciation
DepreciationCr
121723486360677987
PBT
PBTCr
6388107136144178185203204
Tax
TaxCr
182327393747495353
PAT
PATCr
46658098107131136149151
Growth
PAT Growth%
42.822.722.19.821.94.39.411.6
NPM
NPM%
8.810.911.36.66.57.16.66.25.9
EPS
EPS₹
9.413.415.617.819.523.724.726.927.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
410101111111111
Reserves
ReservesCr
1192773987949041,0371,1741,322
Current Liabilities
Current LiabilitiesCr
122149150295349425537790
Non Current Liabilities
Non Current LiabilitiesCr
4362157104100174166
Total Liabilities
Total LiabilitiesCr
2504725611,2571,3681,5721,8962,289
Current Assets
Current AssetsCr
1603263556097208441,0421,236
Non Current Assets
Non Current AssetsCr
901452076476477298541,053
Total Assets
Total AssetsCr
2504725611,2571,3681,5721,8962,289
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
410101111111111
Reserves
ReservesCr
1192773987949041,0371,1741,322
Current Liabilities
Current LiabilitiesCr
122149150295349425537790
Non Current Liabilities
Non Current LiabilitiesCr
4362157104100174166
Total Liabilities
Total LiabilitiesCr
2504725611,2571,3681,5721,8962,289
Current Assets
Current AssetsCr
1603263556097208441,0421,236
Non Current Assets
Non Current AssetsCr
901452076476477298541,053
Total Assets
Total AssetsCr
2504725611,2571,3681,5721,8962,289

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
715748291524313765
Investing Cash Flow
Investing Cash FlowCr
-36-190-37-299-181-103-184-219
Financing Cash Flow
Financing Cash FlowCr
-29157-25292611665186
Net Cash Flow
Net Cash FlowCr
623-142232-441932
Free Cash Flow
Free Cash FlowCr
27-19-8-7120-83-21-175
CFO To PAT
CFO To PAT%
155.887.159.730.1141.333.1100.843.6
CFO To EBITDA
CFO To EBITDA%
91.854.338.716.068.017.351.922.8
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
715748291524313765
Investing Cash Flow
Investing Cash FlowCr
-36-190-37-299-181-103-184-219
Financing Cash Flow
Financing Cash FlowCr
-29157-25292611665186
Net Cash Flow
Net Cash FlowCr
623-142232-441932
Free Cash Flow
Free Cash FlowCr
27-19-8-7120-83-21-175
CFO To PAT
CFO To PAT%
155.887.159.730.1141.333.1100.843.6
CFO To EBITDA
CFO To EBITDA%
91.854.338.716.068.017.351.922.8

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,3885,0303,2843,7263,3442,0952,421
Price To Earnings
Price To Earnings
67.251.530.628.524.514.016.1
Price To Sales
Price To Sales
7.63.42.02.01.60.90.9
Price To Book
Price To Book
13.26.33.63.62.81.61.8
EV To EBITDA
EV To EBITDA
42.927.214.515.313.28.59.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
28.933.630.421.224.924.624.423.823.8
OPM
OPM%
15.017.417.412.413.513.612.711.911.7
NPM
NPM%
8.810.911.36.66.57.16.66.25.9
ROCE
ROCE%
51.926.326.918.316.816.914.513.113.1
ROE
ROE%
36.922.819.612.111.712.511.511.211.2
ROA
ROA%
18.313.814.37.87.88.37.26.56.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,3885,0303,2843,7263,3442,0952,421
Price To Earnings
Price To Earnings
67.251.530.628.524.514.016.1
Price To Sales
Price To Sales
7.63.42.02.01.60.90.9
Price To Book
Price To Book
13.26.33.63.62.81.61.8
EV To EBITDA
EV To EBITDA
42.927.214.515.313.28.59.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
28.933.630.421.224.924.624.423.823.8
OPM
OPM%
15.017.417.412.413.513.612.711.911.7
NPM
NPM%
8.810.911.36.66.57.16.66.25.9
ROCE
ROCE%
51.926.326.918.316.816.914.513.113.1
ROE
ROE%
36.922.819.612.111.712.511.511.211.2
ROA
ROA%
18.313.814.37.87.88.37.26.56.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Rossari Biotech Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/fnvu8ouwek5d78aphned7djr.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/vtvdcmc370mn32hqp3mg0i6n.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/tx54i9x53lx9yb56gnicm843.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/siv4ib9l61bc2erltrp2hwk4.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/elq59cmncocajv2zklmkjnst.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/42lvvjnuob6w1c570degs9a8.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/ipnhf8rovq3i9lrwscvcky6y.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/udsvbv8blnyck2nl5kovaogw.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/15lwp1kkmj5bey2h9pbwre2z.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/vkpe6w2hsoo9y5vqk4edcpq2.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/7mnht4vldxya73uy1wdl5h0p.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/udnk6yjryyba1635urk99fcg.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/ovv0fd0g877b0wj0jxnwg0om.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/v5iilj5x3mj4rn1tj44p21rc.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/nclo28witrrkhdbflqvfmje5.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/2mp04yzx8nsn28b5x6fbskce.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/w1v2wcky6kmkbug5k64geh28.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/b9nwp760kqt5a8xnk9obhodh.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/657wdxuhdio4ytqofq2dn66m.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/itr1jcftvvlt6dcag49x2fwu.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/76ocfg4hwvohfwri0yto9s0b.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/1bisflgvlk7mnifzr6zu1kax.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/7ptgodoxd6x1tlf9gwy5ctgw.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/hdlafsydhg572y8mfctbvqh2.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/f7fw5o93jggzjz8cv9sns0xm.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/86j2977e4bhtsr8zwokbynvp.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/7lqg7p1bwcbcs54uazitz40m.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/5f81nw92hjltk20fp1bk5vcb.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/spe5bln3rr3afjoeishuiebt.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/gtxkaibk39aqm1u6luwsu3cd.pdf

Concall Transcript Summaries — Rossari Biotech Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AROSSARI/transcript-notes/202606/fnvu8ouwek5d78aphned7djr.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AROSSARI/transcript-notes/202603/vtvdcmc370mn32hqp3mg0i6n.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AROSSARI/transcript-notes/202512/tx54i9x53lx9yb56gnicm843.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AROSSARI/transcript-notes/202509/siv4ib9l61bc2erltrp2hwk4.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AROSSARI/transcript-notes/202506/elq59cmncocajv2zklmkjnst.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AROSSARI/transcript-notes/202503/42lvvjnuob6w1c570degs9a8.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AROSSARI/transcript-notes/202412/ipnhf8rovq3i9lrwscvcky6y.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AROSSARI/transcript-notes/202409/udsvbv8blnyck2nl5kovaogw.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies